<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03979716</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A03215-50</org_study_id>
    <nct_id>NCT03979716</nct_id>
  </id_info>
  <brief_title>Smell Exploration in Patients With Nasal Polyposis : Study by Functional Magnetic Resonance Imaging</brief_title>
  <acronym>ODORAT_IRMf</acronym>
  <official_title>Exploration de l'Odorat en Imagerie Par Résonance Magnétique Fonctionnelle Chez Les Patients Atteints de Polypose Nasosinusienne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nasal polyposis (NP) is a disease affecting 4% of the population. This disease is frequently
      accompanied by olfactory disorders (41%-84% of patients) that affect patients' quality of
      life.

      The aim of this study is to show brain activity differences in olfactory areas before and
      after surgery in each patient and between patient groups (normosmic, hyposmic and anosmic
      one) using functional Magnetic Resonance Imaging (fMRI). Brain activity will be measured by
      the intensity of brain signals and of the size of olfactory areas during olfactory
      stimulation before and after surgery. We suppose that fMRI could predict whether or not the
      patient will be able to recover smell after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Brain activity</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Blood Oxygen Level Dependent (BOLD) measures in olfactory areas during calibrated olfactory stimuli in patients with NP whose olfactory function is clinically normal (normosmia), decreased (hyposmia) or absent (anosmia).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Brain activity</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Changes in Blood Oxygen Level Dependent (BOLD) measurements in olfactory areas during calibrated olfactory stimuli before and after NP surgery.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nasal Polyposis</condition>
  <arm_group>
    <arm_group_label>Anosmic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyposmic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Normosmic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>fMRI examination</description>
    <arm_group_label>Anosmic patients</arm_group_label>
    <arm_group_label>Hyposmic patients</arm_group_label>
    <arm_group_label>Normosmic patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with nasal polyposis managed in the department of otorhinolaryngology and
             head and neck surgery of Nancy University Hospital,

          -  Adult Patients,

          -  Justifying a surgical treatment for nasal polyposis,

          -  Present hyposmia, anosmia or normosmia before surgery (confirmed by threshold and
             identification tests of the Sniffin' Stick kit),

          -  Affiliated with or beneficiary of a social security scheme,

          -  Having received complete information about the study and having signed an informed
             consent form.

        Exclusion Criteria:

          -  General contraindications to Magnetic Resonance Imaging,

          -  Female of childbearing age without effective contraception,

          -  Persons referred in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health
             Code,

          -  Qualitative sense of smell disorder (cacosmia, hyperosmia, phantosmia, parosmia),

          -  Smell disorders with neurological, post-traumatic, or neurodegenerative origin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Duc Trung NGUYEN, MD, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Nancy, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Duc Trung NGUYEN, MD, PhD, MPH</last_name>
    <phone>33383155409</phone>
    <email>dt.nguyen@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela HOSSU, PhD</last_name>
    <phone>33383155096</phone>
    <email>g.hossu@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Duc Trung NGUYEN, MD, PhD, MPH</last_name>
      <phone>33383155409</phone>
      <email>dt.nguyen@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 23, 2019</study_first_submitted>
  <study_first_submitted_qc>June 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>June 6, 2019</last_update_submitted>
  <last_update_submitted_qc>June 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

